Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection

NCT04690387 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aivita Biomedical, Inc.

Collaborators